HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Robert A Harrington Selected Research

ST Elevation Myocardial Infarction

6/2022Effects of early myocardial reperfusion and perfusion on myocardial necrosis/dysfunction and inflammation in patients with ST-segment and non-ST-segment elevation acute coronary syndrome: results from the PLATelet inhibition and patients Outcomes (PLATO) trial.
2/2022Diagnosis and Treatment of Acute Coronary Syndromes: A Review.
3/2019Characteristics and outcomes of patients requiring bailout use of glycoprotein IIb/IIIa inhibitors for thrombotic complications of percutaneous coronary intervention: An analysis from the CHAMPION PHOENIX trial.
1/2018The efficacy of early versus delayed P2Y12 inhibition in percutaneous coronary intervention for ST-elevation myocardial infarction: a systematic review and meta-analysis.
1/2018Discharge timing and outcomes after uncomplicated non-ST-segment elevation acute myocardial infarction.
4/2016Safety and efficacy of ticagrelor and clopidogrel in primary percutaneous coronary intervention.
5/2015Glycoprotein IIb/IIIa Receptor Inhibitors in Combination With Vorapaxar, a Platelet Thrombin Receptor Antagonist, Among Patients With Non-ST-Segment Elevation Acute Coronary Syndromes (from the TRACER Trial).
11/2013EPC mobilization after erythropoietin treatment in acute ST-elevation myocardial infarction: the REVEAL EPC substudy.
8/2011Intramyocardial, autologous CD34+ cell therapy for refractory angina.
5/2011Intravenous erythropoietin in patients with ST-segment elevation myocardial infarction: REVEAL: a randomized controlled trial.
For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Robert A Harrington Research Topics

Disease

174Acute Coronary Syndrome
10/2023 - 07/2001
171Myocardial Infarction
04/2024 - 07/2001
127Hemorrhage
04/2024 - 01/2002
60Thrombosis (Thrombus)
03/2024 - 05/2002
58Stroke (Strokes)
04/2024 - 12/2002
47Ischemia
04/2024 - 02/2002
28Unstable Angina
01/2022 - 07/2001
27Cardiovascular Diseases (Cardiovascular Disease)
02/2024 - 06/2002
26Coronary Artery Disease (Coronary Atherosclerosis)
04/2024 - 01/2002
26ST Elevation Myocardial Infarction
06/2022 - 04/2003
21Coronary Disease (Coronary Heart Disease)
04/2024 - 05/2002
19Heart Failure
01/2018 - 01/2003
15Venous Thromboembolism
02/2023 - 09/2004
15Infarction (Infarctions)
11/2013 - 06/2002
13Diabetes Mellitus
04/2024 - 06/2005
10Ischemic Stroke
04/2024 - 09/2004
9Chronic Renal Insufficiency
04/2024 - 03/2008
9Atrial Fibrillation
03/2023 - 09/2004
7Venous Thrombosis (Deep-Vein Thrombosis)
12/2018 - 03/2017
6Type 2 Diabetes Mellitus (MODY)
04/2024 - 05/2019
6Pathologic Constriction (Stenosis)
01/2023 - 11/2008
6Intracranial Hemorrhages (Intracranial Hemorrhage)
01/2022 - 04/2003
5Hypersensitivity (Allergy)
04/2024 - 09/2004
5Vascular Diseases (Vascular Disease)
11/2022 - 07/2003
5Renal Insufficiency (Renal Failure)
01/2019 - 09/2006
5Stable Angina
11/2018 - 05/2012
5Myocardial Ischemia (Ischemic Heart Diseases)
01/2018 - 10/2004
5Pulmonary Embolism
01/2018 - 03/2017
4Hypertension (High Blood Pressure)
09/2022 - 09/2006
4Inflammation (Inflammations)
06/2022 - 04/2007
4Necrosis
06/2022 - 03/2008
4Non-ST Elevated Myocardial Infarction
02/2022 - 04/2007
4Dyslipidemias (Dyslipidemia)
01/2022 - 08/2014
4Cerebrovascular Disorders (Cerebrovascular Occlusion)
11/2013 - 07/2003
4Reperfusion Injury
11/2013 - 11/2005
4Cardiogenic Shock
12/2012 - 04/2007

Drug/Important Bio-Agent (IBA)

66Clopidogrel (Plavix)FDA Link
11/2022 - 09/2004
40Aspirin (Acetylsalicylic Acid)FDA LinkGeneric
04/2024 - 06/2002
38TicagrelorIBA
04/2024 - 11/2007
34Eptifibatide (Integrilin)FDA Link
04/2017 - 07/2001
33cangrelorIBA
03/2022 - 03/2006
33Glycoproteins (Glycoprotein)IBA
01/2018 - 01/2002
21vorapaxarIBA
11/2022 - 03/2009
20Thrombin Receptors (Thrombin Receptor)IBA
11/2022 - 01/2012
19alirocumabIBA
04/2024 - 11/2014
19Enoxaparin (Lovenox)FDA LinkGeneric
02/2023 - 10/2003
17Platelet Membrane GlycoproteinsIBA
02/2008 - 07/2001
16Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA
03/2023 - 07/2004
16Biomarkers (Surrogate Marker)IBA
11/2022 - 02/2004
15AnticoagulantsIBA
03/2023 - 05/2002
15Heparin (Liquaemin)FDA LinkGeneric
03/2019 - 08/2002
15Platelet Membrane Glycoprotein IIbIBA
01/2018 - 12/2002
13omega-Chloroacetophenone (Mace)IBA
04/2024 - 11/2012
13betrixabanIBA
02/2023 - 11/2016
11paragonIBA
12/2010 - 02/2002
10LDL CholesterolIBA
03/2023 - 11/2008
10CreatinineIBA
08/2016 - 07/2003
9apixabanIBA
01/2020 - 06/2009
9StreptokinaseFDA Link
09/2019 - 07/2002
9bivalirudin (Angiomax)FDA Link
01/2017 - 02/2003
9MB Form Creatine KinaseIBA
11/2009 - 09/2003
8fibrin fragment D (D-dimer)IBA
02/2023 - 03/2017
8AntithrombinsIBA
09/2010 - 02/2003
8TenecteplaseFDA Link
03/2005 - 04/2003
7oxidized low density lipoproteinIBA
12/2020 - 11/2008
7Tissue Plasminogen Activator (Alteplase)FDA Link
01/2018 - 09/2004
7EnzymesIBA
05/2014 - 02/2002
6CholesterolIBA
04/2024 - 11/2007
6C-Reactive ProteinIBA
09/2022 - 04/2010
6pro-brain natriuretic peptide (1-76)IBA
06/2022 - 01/2014
6TroponinIBA
02/2022 - 01/2006
6Proprotein Convertase 9IBA
01/2022 - 11/2018
6Purinergic P2Y Receptor AntagonistsIBA
12/2018 - 11/2007
6Factor Xa InhibitorsIBA
01/2017 - 05/2002
5Growth Differentiation Factor 15IBA
11/2022 - 01/2014
5Glucose (Dextrose)FDA LinkGeneric
01/2019 - 03/2010
5Platelet Aggregation Inhibitors (Antiplatelet Drugs)IBA
12/2015 - 07/2003
5Abciximab (ReoPro)FDA Link
03/2006 - 09/2002
4HDL LipoproteinsIBA
04/2024 - 08/2014
4CSL112IBA
04/2024 - 10/2016
4Apolipoprotein A-I (Apolipoprotein A1)IBA
04/2024 - 10/2016
4Lipoprotein(a)IBA
10/2023 - 01/2020
4Brain Natriuretic Peptide (Natrecor)FDA Link
11/2022 - 10/2017
4Lipoproteins (Lipoprotein)IBA
09/2022 - 01/2019
4Peptide Hydrolases (Proteases)FDA Link
12/2018 - 03/2014
4CalciumIBA
12/2016 - 01/2007
4Fibrinolytic Agents (Antithrombotic Agents)IBA
06/2015 - 09/2004
4MetalsIBA
09/2014 - 01/2007
4Creatine Kinase (Creatine Phosphokinase)IBA
11/2009 - 01/2006

Therapy/Procedure

123Therapeutics
04/2024 - 07/2001
81Percutaneous Coronary Intervention
01/2023 - 06/2002
46Stents
03/2024 - 02/2003
39Coronary Artery Bypass (Coronary Artery Bypass Surgery)
01/2023 - 01/2002
12Blood Transfusion (Blood Transfusions)
10/2023 - 07/2004
11Patient Readmission
01/2018 - 07/2008
10Secondary Prevention
02/2024 - 08/2003
10Thrombolytic Therapy
02/2022 - 01/2003
7Drug-Eluting Stents
03/2019 - 06/2003
4Conservative Treatment
04/2024 - 01/2018
4Cardiopulmonary Bypass (Heart-Lung Bypass)
01/2017 - 04/2008